Development of transdermal system containing nicotine by using sustained release dosage design

Farmaco

Volumn 60, Issue 9, 2005, Pages 763-770

  Tirnaksiz, Figen ^a   Yuce, Zeynep ^b  

^a GAZI UNIVERSITY   (Turkey)

^b MINISTRY OF HEALTH   (Turkey)

Author keywords

Nicotine; Polyethylene membrane; Sustained release dosage form design; Transdermal delivery systems

Indexed keywords

CARBOMER; CARBOPOL 934; NICOTINE; POLYETHYLENE; PROPYLENE GLYCOL; PSYCHOTROPIC AGENT;

AB INITIO CALCULATION; ARTICLE; ARTIFICIAL MEMBRANE; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG PENETRATION; IN VITRO STUDY; SUSTAINED DRUG RELEASE; THERMODYNAMICS;

ADMINISTRATION, CUTANEOUS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DELAYED-ACTION PREPARATIONS; DIFFUSION; DRUG STABILITY; NICOTINE; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 24944573063     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.farmac.2005.06.004     Document Type: Article

References (33)

1. M. Fiore, D.E. Jorenby, T.B. Baker, and S.L. Kenford Tobacco dependence and the nicotine patch J. Am. Med. Assoc. 268 1992 2687 2694
2. C.K. Svenson Clinical pharmacokinetics of nicotine Clin. Pharmacokinet. 12 1987 30 40
3. E.W. Lee G.E. D'Alonzo, Cigarette smoking, nicotine addiction, and its pharmacologic treatment Arch. Intern. Med. 153 1993 34 48
4. N.L. Benowitz Nicotine replacement therapy Drugs 45 1993 157 170
5. S.G. Gourlay, and J.J. McNeil Antismoking products Med. J. Aust. 153 1990 699 707
6. N.G. Schneider Nicotine therapy in smoking cessation Clin. Pharmacokinet. 23 1992 169 172
7. A.V. Gore, and Y.W. Chien The nicotine transdermal system Clin. Dermatol. 16 5 1998 599 615
8. K.J. Palmer, M.M. Buckley, and D. Faulds Transdermal nicotine Drugs 44 1992 498 529
9. R. Wolf, B. Tüzün, and Y. Tüzün Adverse skin reactions to the nicotine transdermal system Clin. Dermatol. 16 1998 617 623
10. B. Berner, C. Mazzenga, P.M. Gargiulo, and R.A. Steffens Transdermal nicotine system: feasibility studies J. Control. Release 20 1992 13 20
11. Y.W. Chien Transdermal systemic drug delivery - recent development and future prospects STP Pharm. Sci. 1 1991 15 23
12. A. D'Mello Transdermal Patch Drug Delivery 1995 Scrip Reports PJB Publication New York 1 7
13. C. Valenta, and B.G. Auner The use of polymers for dermal and transdermal delivery Eur. J. Pharm. Biopharm. 58 2 2004 279 289
14. A.C. Moffat Clarke's Isolation and Identification of Drugs Pharmaceuticals, Body Fluids and Post-Mortem Material 1986 The Pharmaceutical Press London 807 808
15. D. Lewis, M.I. Paulo, E. Faustino, and A. Farinha In vitro comparative studies of transdermal nicotine delivery systems Int. J. Pharm. 147 1997 177 189
16. F. Tirnaksiz Ocak, and I. Aǧabeyoǧlu Development of a membrane controlled transdermal therapeutic system containing isosorbide dinitrate Int. J. Pharm. 180 1999 177 183
17. Z. Yüce, and F. Tirnaksiz Ocak Basic studies on membrane controlled transdermal delivery of nicotine using ethylene-vinyl acetate copolymer membrane, Fourth Int 1995 Sym. Pharm. Sci. Ankara, Turkey
18. Anon Technical data sheet 1998 3M Laboratories-Europe
19. V.P. Shah, N.W. Tymes, W. Ment, and J.P. Skelly Collaborative study result of a dissolution test procedure developed by FDA for nitroglycerin transdermal delivery systems Pharmacopeial Forum 14 1988 3458 3462
20. ® Int. J. Pharm. 252 2003 133 140
21. R.H. Guy, and J. Hadgraft Pharmacokinetic interpretation of the plasma level of clonidine following transdermal delivery J. Pharm. Sci. 74 1985 1016 1018
22. Y.N. Kalia, and R.H. Guy Modeling transdermal drug release Adv. Drug Deliv. Rev. 48 2001 159 172
23. J.R. Robinson, and S.P. Eriksen Theoretical formulation of sustained release dosage forms J. Pharm. Sci. 55 1996 1254 1263
24. S.K. Gupta, N.L. Benowitz III, P. Jacop, C.N. Rolf, and J. Gorsline Bioavailability and absorption kinetics of nicotine following application of a transdermal system Br. J. Clin. Pharm. 36 1993 221 227
25. J.G. Wagner Fundamentals of Clinical Pharmacokinetics 1979 Drug Intelligence Pub., Inc., Hamilton IL, USA 286
26. M.R. Carlisle, M.L. Chicoine, and M.B. Wygant A stability indicating high performance liquid chromatographic assay for nicotine in transdermal patches Int. J. Pharm. 80 1992 227 242
27. Y.S.R. Krishnaiah, V. Satyanarayana, and P. Bhaskar Influence of menthol and pressure-sensitive adhesives on the in vivo performance of membrane-moderated transdermal therapeutic system of nicardipine hydrochloride in human volunteers Eur. J. Pharm. Biopharm. 55 2003 329 337
28. J.Y. Fang, S.S. Chen, Y.B. Huang, P.C. Wu, and Y.H. Tsai In vitro study of transdermal nicotine delivery: influence of rate-controlling membranes and adhesives Drug Dev. Ind. Pharm. 25 6 1999 789 794
29. J.C. Shah Analysis of permeation data: evaluation of lag time method Int. J. Pharm. 90 1993 161 169
30. H. Ho, and Y.W. Chien Kinetic evaluation of transdermal nicotine delivery systems Drug Dev. Ind. Pharm. 19 1993 295 313
31. Y.W. Chien Recent advances in noninvasive systemic delivery of pharmaceuticals and biopharmaceuticals Drug Dev. Ind. Pharm. 20 1994 417 468
32. S. Lin, H. Ho, and Y.W. Chien Development of a new nicotine transdermal delivery system: in vitro kinetics studies and clinical pharmacokinetic evaluations in two ethnic groups J. Control. Release 26 1993 175 193
33. R. Woodford, and B.M. Barry Optimization of bioavailability of topical steroids: thermodynamic control J. Invest. Dermatol. 79 1982 388 391